Random copeptin measurement |
Any time |
>21.4 pmol/L = nephrogenic diabetes insipidus |
Diagnostic accuracy 100% |
Timper K, et al. J Clin Endocrinol Metab 2015 (41) |
Hypertonic saline infusion test |
Once plasma sodium ≥147 mmol/L |
≤4.9 pmol/L = central diabetes insipidus |
Diagnostic accuracy 97% |
Fenske W, et al. N Engl J Med 2018 (43) |
|
|
>4.9 pmol/L = primary polydipsia |
|
Timper K, et al. J Clin Endocrinol Metab 2015 (41) |
Arginine infusion test |
60 minutes after start of arginine infusion |
≤3.8 pmol/L = central diabetes insipidus |
Diagnostic accuracy 93% |
Winzeler B, et al. Lancet 2019 (44) |
|
|
>3.8 pmol/L = primary polydipsia |
|
|
Pituitary surgery stimulated copeptin |
1st postoperative day |
<2.5 pmol/L = central diabetes insipidus |
Positive predictive value 81%, specificity 97% |
Winzeler B, et al. J Clin Endocrinol Metab 2015 (48) |
|
|
>30 pmol/L = no central diabetes insipidus |
Negative predictive value 95%, sensitivity 94% |
|
Hypernatremia in hospitalized patients |
Plasma sodium >155 mmol/L |
≤4.4 pmol/L = central diabetes insipidus |
Sensitivity 100%, specificity 99% |
Nigro N, et al. Crit Care 2018 (49) |
Hyponatremia in hospitalized patients |
Plasma sodium <125 mmol/L |
>84 pmol/L = hypovolemic hyponatremia |
Sensitivity 23%, specificity 90% |
Nigro N, et al. Clin Endocrinol 2017 (50) |
|
|
<3.9 pmol/L = primary polydipsia |
Sensitivity 58%, specificity 91% |
|